AMPLIRUN® TOTAL SARS-CoV-2 CONTROL

Amplirun Total1.jpg

Inactivated SARS-CoV-2 virus formulated in viral transport medium to validate and control molecular analyses for the diagnosis of COVID-19

  • External quality control for nucleic acids detection
  • Validation of the complete analytical process: extraction & amplification
  • Complete inactivated microorganism in a matrix
  • Quantified controls (low positive)
  • 10 single-use lyophilized vials 

> Further information available for the design of primers and probes:
· SARS-CoV-2 complete genome: EPI_ISL_429256

Product AMPLIRUN® TOTAL SARS-COV-2 CONTROL (SWAB)
Volumen:
500 μL
Reference
MBTC030
Nº Test
10
CE

The use of AmpliRun® Total Controls will enable your lab to:

  • Enhance the quality of the whole testing process: extraction and amplification.
  • Monitor all aspects of sample testing and instrument performance in the long term.
  • Monitor variations in laboratory procedures, including batches of assay reagents.
  • Validate and verify new assays.
  • Obtain reliable and comparable results.
  • Train laboratory personnel/ trial purposes.
  • Take corrective actions prior assay failure and detect and troubleshoot suspect results.
  • Comply with lab accreditation requirements.
Product AMPLIRUN® TOTAL SARS-COV-2 CONTROL (SWAB)
Volumen:
500 μL
Reference
MBTC030
Nº Test
10
CE

The use of AmpliRun® Total Controls will enable your lab to:

  • Enhance the quality of the whole testing process: extraction and amplification.
  • Monitor all aspects of sample testing and instrument performance in the long term.
  • Monitor variations in laboratory procedures, including batches of assay reagents.
  • Validate and verify new assays.
  • Obtain reliable and comparable results.
  • Train laboratory personnel/ trial purposes.
  • Take corrective actions prior assay failure and detect and troubleshoot suspect results.
  • Comply with lab accreditation requirements.
Ask for information
Information request
If you need more information about the product, please fill in the form.